Soymilk or progesterone for prevention of bone loss--a 2 year randomized, placebo-controlled trial.
about
The pharmacokinetic behavior of the soy isoflavone metabolite S-(-)equol and its diastereoisomer R-(+)equol in healthy adults determined by using stable-isotope-labeled tracersOne year soy protein supplementation has positive effects on bone formation markers but not bone density in postmenopausal womenTransdermal natural progesterone cream for postmenopausal women: inconsistent data and complex pharmacokinetics.Natural health products in the prevention and treatment of osteoporosis: systematic review of randomized controlled trials.Soy isoflavone supplementation and bone mineral density in menopausal women: a 2-y multicenter clinical trial.Neonatal administration of isoflavones attenuates deterioration of bone tissue in female but not male mice.Dietary patterns associated with fall-related fracture in elderly Japanese: a population based prospective study.Equol, via dietary sources or intestinal production, may ameliorate estrogen deficiency-induced bone lossDesign and baseline characteristics of the soy phytoestrogens as replacement estrogen (SPARE) study--a clinical trial of the effects of soy isoflavones in menopausal womenBrief telephone intervention increases soy intake in peri- and postmenopausal US women: the Herbal Alternatives Trial (HALT)Preference Mapping of Soymilk with Different U.S. Consumers.Epimedium-derived phytoestrogen flavonoids exert beneficial effect on preventing bone loss in late postmenopausal women: a 24-month randomized, double-blind and placebo-controlled trial.Soy protein supplementation does not cause lymphocytopenia in postmenopausal women.Impact of perinatal exposure to equol enantiomers on reproductive development in rodents.Soy milk and dairy consumption is independently associated with ultrasound attenuation of the heel bone among postmenopausal women: the Adventist Health Study-2Soy and red clover for mid-life and aging.The effect of soy isoflavone on bone mineral density in postmenopausal Taiwanese women with bone loss: a 2-year randomized double-blind placebo-controlled study.Impact of equol-producing capacity and soy-isoflavone profiles of supplements on bone calcium retention in postmenopausal women: a randomized crossover trialKanamycin inhibits daidzein metabolism and abilities of the metabolites to prevent bone loss in ovariectomized mice.Short-Term Isoflavone Intervention in the Treatment of Severe Vasomotor Symptoms after Surgical Menopause: A Case Report and Literature ReviewPhytoestrogens: end of a tale?Soy Isoflavones and Osteoporotic Bone Loss: A Review with an Emphasis on Modulation of Bone Remodeling.Effect of a combination of genistein, polyunsaturated fatty acids and vitamins D3 and K1 on bone mineral density in postmenopausal women: a randomized, placebo-controlled, double-blind pilot study.Effects of soy protein isolate and moderate exercise on bone turnover and bone mineral density in postmenopausal women.Alternative therapies for osteoporosis.Long-term effects of progestins on bone quality and fractures.Phyto-oestrogens and bone health.Soy isoflavones do not affect bone resorption in postmenopausal women: a dose-response study using a novel approach with 41Ca.Soy proteins and isoflavones affect bone mineral density in older women: a randomized controlled trialDietary factors influence production of the soy isoflavone metabolite s-(-)equol in healthy adultsDietary phyto-oestrogens: molecular mechanisms, bioavailability and importance to menopausal health.Antiresorptive effects of phytoestrogen supplements compared with estradiol or risedronate in postmenopausal women using (41)Ca methodology.The soy isoflavones for reducing bone loss (SIRBL) study: a 3-y randomized controlled trial in postmenopausal women.Antiosteoporotic Activity of Genistein Aglycone in Postmenopausal Women: Evidence from a Post-Hoc Analysis of a Multicenter Randomized Controlled Trial.Dietary equol and bone metabolism in postmenopausal Japanese women and osteoporotic mice.Isoflavones: effects on bone health.Emerging evidence of the health benefits of S-equol, an estrogen receptor β agonist.Phytoestrogens and bone health at different reproductive stages.Alveolar bone loss: mechanisms, potential therapeutic targets, and interventions.Isoflavone supplementation in postmenopausal women does not affect leukocyte LDL receptor and scavenger receptor CD36 expression: A double-blind, randomized, placebo-controlled trial.
P2860
Q24653795-BAE901EA-1E07-468A-B466-3515613E6ABCQ24800268-D69032FF-6EB1-4294-9A33-61DED5533D3FQ31136140-0126EB3C-7756-4AA0-B2D9-E2455FDFA875Q33242024-7A31C82B-712C-4AA3-8B8B-E2379FC776ADQ33503980-FAC029C8-33E9-4DE7-AB35-3A9B99076706Q33531992-EFAA2048-1AD6-447A-ADE7-72F71F0C55DFQ33591001-E33AF4EB-CD99-4E08-A487-4C68B4F242EFQ33908748-EE996238-466B-4766-989C-979036DFB82CQ33936477-13EB8878-BDED-4B80-B587-3702CFB2D204Q34116673-D30DC324-064A-4B5D-B22B-B03F7E8E9FE6Q34505476-F81D9469-10E0-4F63-999B-AFC9C3BB65E2Q34617383-02E83F0E-0AF9-4286-8021-76CC257DA621Q34691088-34D23A01-C314-4EA9-8C7D-87DF3A79DB1DQ35234941-4214E35F-8055-4F9B-9EFF-98A3CEAC50E6Q35555572-10FEB99B-69C6-456A-97E7-AFB3BE97E02EQ35606928-A361E1C7-796C-4D0B-BCF5-774809241933Q35904536-BBE89236-4496-406E-AAA1-7BBDC3129CE1Q35992562-F37CB9BA-06B1-4725-B462-DBB853CCE4B0Q36070323-3BFD7E01-B9EC-46BC-8102-A7EADA0A9273Q36271933-CC24B41D-FC4F-477A-B412-BDABEA119608Q36276300-3BD97D69-A1CD-484E-9FA8-3939BEF88961Q36475945-6836C547-FABD-4F35-9DCF-202FF81086CAQ36546641-3C64B371-5D47-49C9-B504-C6CE4F5F44E7Q36631511-372ADC72-37AB-4E08-8ED1-99DB496E4823Q36642341-D57C216D-58C4-4C00-ABFE-6F388F61A5BAQ36974429-7679062A-CA11-4BB4-B427-4431EE965FAAQ37138656-354DAA77-0942-418B-AE62-82B1A6E16CECQ37196774-5AB7E928-ED8C-4CC7-870C-7E159C5CB769Q37229025-B2310182-549D-436B-9B0A-A78A38911282Q37307326-3435D297-BC5C-44DE-8053-80AB4F8DA522Q37350043-9DF2B1E2-EDB1-42D7-B47C-9C0BFBA46FC3Q37379505-3616F355-8D3E-48FE-8A82-6F41E75E58C7Q37474722-E68C4828-9F05-4EFF-A6AD-8CA573484770Q37673312-145AEE6B-5CDA-4EBD-9D9C-F352DE44B75FQ37756425-29BB51F1-25E0-42A5-B28F-120EE8297B8EQ37810256-C18AE73A-5CAD-4906-B8E3-2C3575A53298Q37905857-8E0FD8B7-F1AC-4D6C-8833-E0B65C15AA29Q38112453-25E5E6BD-689A-4144-BCC3-11428F83DAE2Q38204892-0921D171-18E3-4409-8FA7-589B7DF4D649Q39897563-A79122AA-4915-47D6-A2FA-B84FFF442B23
P2860
Soymilk or progesterone for prevention of bone loss--a 2 year randomized, placebo-controlled trial.
description
2004 nî lūn-bûn
@nan
2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Soymilk or progesterone for pr ...... zed, placebo-controlled trial.
@ast
Soymilk or progesterone for pr ...... zed, placebo-controlled trial.
@en
type
label
Soymilk or progesterone for pr ...... zed, placebo-controlled trial.
@ast
Soymilk or progesterone for pr ...... zed, placebo-controlled trial.
@en
prefLabel
Soymilk or progesterone for pr ...... zed, placebo-controlled trial.
@ast
Soymilk or progesterone for pr ...... zed, placebo-controlled trial.
@en
P2093
P1476
Soymilk or progesterone for pr ...... zed, placebo-controlled trial.
@en
P2093
Eva Lydeking-Olsen
Jens-Erik Beck-Jensen
Kenneth D R Setchell
Trine Holm-Jensen
P2888
P304
P356
10.1007/S00394-004-0497-8
P577
2004-04-14T00:00:00Z